Trade Summary

4 days ago, Patusky Christopher, serving as Dir at United Therapeutics Corp (UTHR), sold 1,000 shares at $578.88 per share, for a total transaction value of $578,880.00. Following this transaction, Patusky Christopher now holds 2,590 shares of UTHR.

This sale represents a 28.00% decrease in Patusky Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, April 17, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 17, 2026, meaning the disclosure happened on the same day as the trade.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.